Injective Governance Vote Passes, Accelerating INJ Supply Cuts

Introduction
Injective Protocol’s community-approved tokenomics overhaul marks a pivotal shift toward a stricter deflationary path for its layer-1 DeFi ecosystem. In a governance vote powered by staked voting weight, IIP-617 passed with 99.89% support, enabling reduced issuance for the INJ token while preserving the network’s buyback-and-burn program. The move is designed to accelerate token removal from circulation over time, aligning issuance with recurring burn mechanisms as Injective pushes to attract institutional attention and broader DeFi adoption.

Key Takeaways

• IIP-617 reduces native INJ issuance while preserving the buyback-and-burn program to support long-term deflationary dynamics.
• Approximately 6.85 million INJ have already been removed from circulation through token burns, with the proposal intended to quicken this pace by syncing issuance with buybacks.
• The changes are live and framed by proponents as moving INJ toward becoming one of the more deflationary crypto assets over time.
• Regulatory progress for a staked INJ ETF and ongoing validator network expansion underline Injective’s push into regulated products and institutional participation.

Tickers mentioned: $INJ

Sentiment: Neutral

Price impact: Negative. INJ has faced notable downside as part of a broader altcoin downturn, even as governance progress advances.

Trading idea (Not Financial Advice): Hold. The tokenomics shift is structural and long-horizon oriented, but near-term price action remains sensitive to market sentiment.

Market context: The move comes amid a broader environment of altcoin volatility and growing interest in regulated DeFi products, alongside ongoing governance-driven upgrades across DeFi networks.

Injective sees ETF filings and new validators

In the wake of the IIP-617 vote, Injective’s development trajectory remains defined by institutional engagement and ecosystem expansion. Despite a softer price backdrop, the network has continued to attract regulated market interest and new validators, signaling a multi-pronged push to broaden adoption beyond purely retail participation.

In July, two fund sponsors filed regulatory applications for a staked Injective exchange-traded fund. Cboe and Canary Capital are pursuing funds that would hold INJ to generate staking rewards via a compliant platform. The filings highlight a continued appetite among traditional market participants for crypto exposure that blends yield with governed staking—and they come as regulators increasingly scrutinize on-chain assets and market access.

Beyond regulated products, Injective has steadily expanded its validator set. Earlier, Deutsche Telekom’s IT services arm joined the network as a validator, underscoring the project’s appeal to enterprise-grade participants seeking secure, decentralized financial applications. More recently, Korea University—the oldest institution of higher learning in the country—became the first academic body to operate a validator on Injective and to conduct on-chain research within the network’s framework. The university’s involvement signals growing academic validation of on-chain research capabilities and real-world usage of the protocol’s architecture.

Amid these developments, market metrics have been uneven. DefiLlama’s data show that total value locked across Injective’s DeFi ecosystem stood at about 18.67 million, a material pullback from peaks above 60 million observed in 2024. The erosion in TVL reflects a broader pullback in altcoins and DeFi protocols during the period, even as a governance-driven upgrade aims to stabilize and gradually compress supply.

Community sentiment around the governance vote skewed optimistic. Participants framed IIP-617 not as a speculative price catalyst, but as a structural, long-term adjustment designed to reduce issuance and reinforce token scarcity. With a deflationary trajectory embedded in the protocol’s economics, Injective aims to sustain a sustainable, revenue-backed burn mechanism that could bolster upside potential as usage grows and institutional products mature.

As Injective navigates a challenging price environment, the combination of a formal deflationary framework, renewed regulatory attention, and expanded validator participation positions the project to attract specialized capital looking for DeFi exposure with governance and staking dynamics. The path forward hinges on execution—KEEPING token issuance aligned with burn cycles, delivering consistent validator performance, and expanding the ecosystem’s measured use cases across trading, liquidity provisioning, and cross-chain interoperability.